Medicine and Dentistry
Adverse Event
11%
Cytokine Release
11%
Development
11%
Disease Activity
55%
Gastrointestinal Distress
11%
Intention-to-Treat Analysis
11%
Leukocyte
11%
Nausea and Vomiting
11%
Patient
44%
Phase II Trials
11%
Phosphodiesterase IV
11%
Placebo
100%
Post-Hoc Analysis
22%
Serositis
11%
Spontaneous Remission
11%
Superoxide
11%
Thiazole Derivative
11%
Ulcerative Colitis
100%
INIS
cytokines
20%
diseases
100%
doses
20%
inflammation
20%
investigations
20%
leukocytes
20%
nausea
20%
patients
80%
phosphodiesterases
20%
populations
20%
production
20%
reduction
40%
safety
20%
thiazoles
20%
vomiting
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
11%
Cytokine
11%
Disease Activity
55%
Gastrointestinal Symptom
11%
Inflammation
11%
Nausea and Vomiting
11%
Phosphodiesterase IV
11%
Remission
11%
Superoxide
11%
Tetomilast
100%
Ulcerative Colitis
100%